Novo Nordisk (NVO) has received approval to market its oral GLP-1 medicine Rybelsus in the U.S. to reduce the risk of major ...
Straight Arrow News on MSN
New study sheds light on why GLP-1s could mitigate alcohol abuse
Back in May, a study was published suggesting that popular weight-loss drugs such as Ozempic and Wegovy could curb alcohol cravings by as much as 70%. At the time, researchers weren't entirely sure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback